Discover 3,557 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,557
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
for
Ulcerative Colitis
Location: Garden Grove CA, San Francisco CA, Abilene TX,
Sponsor: Pfizer
Sex: All
Age: 12 - 17
Code: NCT05287126
Phase2, Recruiting
Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
for
Pouchitis, Pouches, Ileoanal, Pouch, Ileal
Location: Los Angeles CA, Rochester MN, Chapel Hill NC,
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18 - 70+
Code: NCT06864403
Recruiting
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
for
Dry Eye
Location: Newport Beach CA, Memphis TN
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07179055
Phase2, Recruiting
Personalized Health Self-Management Training for Colorectal Cancer Survivors
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06910761
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Los Angeles CA, Bakersfield CA, Surprise AZ, Peoria AZ,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06992427
Phase3, Recruiting
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
for
Solid Tumor
Location: Newport Beach CA, West Valley City UT, Denver CO,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06874335
Phase1, Recruiting
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer